BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28545339)

  • 1. Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant.
    Srivastava S; Gubbels CS; Dies K; Fulton A; Yu T; Sahin M
    J Child Neurol; 2017 Aug; 32(9):840-845. PubMed ID: 28545339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, radiological, and genetic characteristics of 16 patients with ACO2 gene defects: Delineation of an emerging neurometabolic syndrome.
    Sharkia R; Wierenga KJ; Kessel A; Azem A; Bertini E; Carrozzo R; Torraco A; Goffrini P; Ceccatelli Berti C; McCormick ME; Plecko B; Klein A; Abela L; Hengel H; Schöls L; Shalev S; Khayat M; Mahajnah M; Spiegel R
    J Inherit Metab Dis; 2019 Mar; 42(2):264-275. PubMed ID: 30689204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel compound heterozygous ACO2 mutations in an infant with progressive encephalopathy: A newly identified neurometabolic syndrome.
    Park JS; Kim MJ; Kim SY; Lim BC; Kim KJ; Seong MW; Lee JS; Chae JH
    Brain Dev; 2020 Oct; 42(9):680-685. PubMed ID: 32713659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2.
    Blackburn PR; Schultz MJ; Lahner CA; Li D; Bhoj E; Fisher LJ; Renaud DL; Kenney A; Ibrahim N; Hashem M; Zain Seidahmed M; Hasadsri L; Schrier Vergano SA; Alkuraya FS; Lanpher BC
    Ann Clin Transl Neurol; 2020 Jun; 7(6):1013-1028. PubMed ID: 32519519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recessive ACO2 variants as a cause of isolated ophthalmologic phenotypes.
    Gibson S; Azamian MS; Lalani SR; Yen KG; Sutton VR; Scott DA
    Am J Med Genet A; 2020 Aug; 182(8):1960-1966. PubMed ID: 32449285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2.
    Spiegel R; Pines O; Ta-Shma A; Burak E; Shaag A; Halvardson J; Edvardson S; Mahajna M; Zenvirt S; Saada A; Shalev S; Feuk L; Elpeleg O
    Am J Hum Genet; 2012 Mar; 90(3):518-23. PubMed ID: 22405087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy.
    Metodiev MD; Gerber S; Hubert L; Delahodde A; Chretien D; Gérard X; Amati-Bonneau P; Giacomotto MC; Boddaert N; Kaminska A; Desguerre I; Amiel J; Rio M; Kaplan J; Munnich A; Rötig A; Rozet JM; Besmond C
    J Med Genet; 2014 Dec; 51(12):834-8. PubMed ID: 25351951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploinsufficiency due to a novel ACO2 deletion causes mitochondrial dysfunction in fibroblasts from a patient with dominant optic nerve atrophy.
    Neumann MA; Grossmann D; Schimpf-Linzenbold S; Dayan D; Stingl K; Ben-Menachem R; Pines O; Massart F; Delcambre S; Ghelfi J; Bohler J; Strom T; Kessel A; Azem A; Schöls L; Grünewald A; Wissinger B; Krüger R
    Sci Rep; 2020 Oct; 10(1):16736. PubMed ID: 33028849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel compound heterozygous mutations in ACO2 in a patient with progressive cerebral and cerebellar atrophy.
    Fukada M; Yamada K; Eda S; Inoue K; Ohba C; Matsumoto N; Saitsu H; Nakayama A
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00698. PubMed ID: 31106992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency.
    Sadat R; Barca E; Masand R; Donti TR; Naini A; De Vivo DC; DiMauro S; Hanchard NA; Graham BH
    Mol Genet Metab; 2016 May; 118(1):28-34. PubMed ID: 26992325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sibling study of isolated optic neuropathy associated with novel variants in the ACO2 gene.
    Kelman JC; Kamien BA; Murray NC; Goel H; Fraser CL; Grigg JR
    Ophthalmic Genet; 2018 Oct; 39(5):648-651. PubMed ID: 30118607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
    Lee J; Jung SC; Hong YB; Yoo JH; Koo H; Lee JH; Hong HD; Kim SB; Chung KW; Choi BO
    Mol Med Rep; 2016 Jul; 14(1):33-40. PubMed ID: 27150940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child Neurology: Progressive Cerebellar Atrophy and Retinal Dystrophy: Clues to an Ultrarare
    Lail N; Pandey AK; Venkatesh S; Noland RD; Swanson G; Pain D; Branson HM; Suzuki CK; Yoon G
    Neurology; 2023 Oct; 101(15):e1567-e1571. PubMed ID: 37460232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in EXOSC2 are associated with a novel syndrome characterised by retinitis pigmentosa, progressive hearing loss, premature ageing, short stature, mild intellectual disability and distinctive gestalt.
    Di Donato N; Neuhann T; Kahlert AK; Klink B; Hackmann K; Neuhann I; Novotna B; Schallner J; Krause C; Glass IA; Parnell SE; Benet-Pages A; Nissen AM; Berger W; Altmüller J; Thiele H; Weber BH; Schrock E; Dobyns WB; Bier A; Rump A
    J Med Genet; 2016 Jun; 53(6):419-25. PubMed ID: 26843489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing identifies rare compound heterozygous mutations in the MSTO1 gene associated with cerebellar ataxia and myopathy.
    Li K; Jin R; Wu X
    Eur J Med Genet; 2020 Jan; 63(1):103623. PubMed ID: 30684668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: from syndromic to nonsyndromic retinal degeneration.
    Nishiguchi KM; Avila-Fernandez A; van Huet RA; Corton M; Pérez-Carro R; Martín-Garrido E; López-Molina MI; Blanco-Kelly F; Hoefsloot LH; van Zelst-Stams WA; García-Ruiz PJ; Del Val J; Di Gioia SA; Klevering BJ; van de Warrenburg BP; Vazquez C; Cremers FP; García-Sandoval B; Hoyng CB; Collin RW; Rivolta C; Ayuso C
    Ophthalmology; 2014 Aug; 121(8):1620-7. PubMed ID: 24697911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal recessive posterior column ataxia with retinitis pigmentosa caused by novel mutations in the FLVCR1 gene.
    Shaibani A; Wong LJ; Wei Zhang V; Lewis RA; Shinawi M
    Int J Neurosci; 2015 Jan; 125(1):43-9. PubMed ID: 24628582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel SACS mutations associated with intellectual disability, epilepsy and widespread supratentorial abnormalities.
    Ali Z; Klar J; Jameel M; Khan K; Fatima A; Raininko R; Baig S; Dahl N
    J Neurol Sci; 2016 Dec; 371():105-111. PubMed ID: 27871429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxia, tremor, intellectual disability: a case of STXBP1 encephalopathy with a new mutation.
    Değerliyurt A; Kesen GG; Ceylaner S
    Turk J Pediatr; 2019; 61(5):757-759. PubMed ID: 32105008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.